Search
01/01/2025
Safety and Effectiveness of Allergen Immunotherapy in Patients with Severe Allergic Asthma
Tabar, AI, Delgado-Romero, J, González-Mancebo, E, Dominguez-Ortega, J, Soto-Retes, L. Safety and Effectiveness of Allergen Immunotherapy in Patients with Severe Allergic Asthma. Journal of Asthma and Allergy. 2025; 18DOI:10.2147/JAA.S546044. PMID:40994702. IF:3.000(Q2/4D).
01/01/2025
Epidemiological, clinical and mortality trends in people with HIV over 60 years in the PISCIS population-based cohort from Catalonia and Balearic Islands
Bruguera, A, Nomah, DK, Moreno-Fornés, S, Martinez, E, Negredo, E, Tiraboschi, J, Navarro, J, Domingo, P, Fanjul, F, Villoslada, A, Peraire, J, Jaen, A, Miró JM, Casabona, J, Reyes-Urueña, J. Epidemiological, clinical and mortality trends in people with HIV over 60 years in the PISCIS population-based cohort from Catalonia and Balearic Islands. AIDS. 2025; 39(1)DOI:10.1097/QAD.0000000000004018. PMID:39639721. IF:3.100(Q2/4D).
01/01/2025
Targeting protein-protein interactions in drug discovery: Modulators approved or in clinical trials for cancer treatment
Camps-Fajol, C, Cavero, D, Minguillon, J, Surralles, J. Targeting protein-protein interactions in drug discovery: Modulators approved or in clinical trials for cancer treatment. PHARMACOLOGICAL RESEARCH. 2025; 211DOI:10.1016/j.phrs.2024.107544. PMID:39667542. IF:10.500(Q1/1D).
01/01/2025
A founder variant in the RYR1 gene is associated with hyperCKemia, myalgia and muscle cramps
Segarra-Casas, A, Iruzubieta, P, Kapetanovic, S, Hernández-Laín, A, Jericó, I, Fernández-Torrón, R, Maneiro, M, Marco-Moreno, P, Zelaya-Huerta, MV, Rodríguez-Santiago, B, Calafell, F, Töpf, A, Straub, V, Vallejo-Illarramendi, A, de Munain, AL, Gallano, P, Gonzalez-Quereda, L. A founder variant in the RYR1 gene is associated with hyperCKemia, myalgia and muscle cramps. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32(1)DOI:10.1111/ene.16471. PMID:39742415. IF:3.900(Q1/3D).
01/01/2025
Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trial
Palmerini, E, Pousa, AL, Grignani, G, Redondo, A, Hindi, N, Provenzano, S, Sebio, A, Martin, JAL, Valverde, C, Trufero, JM, Gutierrez, A, de Alava, E, Gomez, MPA, D'Ambrosio, L, Collini, P, Bazzocchi, A, Moura, DS, Ibrahim, T, Stacchiotti, S, Broto, JM. Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trial. CANCER. 2025; 131(1)DOI:10.1002/cncr.35628. PMID:39540661. IF:5.100(Q1/3D).
01/01/2025
Adjuvant Immunotherapy After Resected Melanoma: Survival Outcomes, Prognostic Factors and Patterns of Relapse
Martinez-Recio, S, Molina-Pérez, MA, Muñoz-Couselo, E, Sevillano-Tripero, AR, Aya, F, Arance, A, Orrillo, M, Martin-Liberal, J, Fernandez-Morales, L, Lesta, R, Quindós-Varela, M, Nieva, M, Vidal, J, Martinez-Perez, D, Barba, A, Majem, M. Adjuvant Immunotherapy After Resected Melanoma: Survival Outcomes, Prognostic Factors and Patterns of Relapse. Cancers. 2025; 17(1)DOI:10.3390/cancers17010143. PMID:39796770. IF:4.400(Q2/3D).